Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
StopStop@HITH
NCT07532941Phase 4Recruiting
- Sponsor
- Murdoch Children's Research Institute
- Start
- Aug 2026
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in cellulitis, urinary tract infection (UTI), lower respiratory tract infection (LRTI) and 1 more (2 arms), sponsored by Murdoch Children's Research Institute. Primary endpoint: Proportion of children with clinical failure within 28 days. Started Aug 2026; status: recruiting.
02
Conditions
cellulitisurinary tract infection (UTI)lower respiratory tract infection (LRTI)lymphadenitis
Beyond the preview
Go deeper on NCT07532941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07532941.